Failure modes of the Carpentier-Edwards pericardial bioprosthesis in the aortic position

Journal of Heart Valve Disease

Volumn 15, Issue 3, 2006, Pages 421-427

  Roselli, Eric E ^a   Smedira, Nicholas G ^a   Blackstone, Eugene H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOPROSTHESIS; EQUIPMENT DESIGN; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INSTRUMENTATION; MALE; MIDDLE AGED; PROSTHESIS FAILURE; RETROSPECTIVE STUDY;

ADULT; AGED; BIOPROSTHESIS; EQUIPMENT DESIGN; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES;

EID: 33750714450     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Banbury MK, Cosgrove DM, III, Thomas JD, et al. Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2002;73:1460-1465
2. Smedira NG, Blackstone EH, Roselli EE, Laffey CC, Cosgrove DM. Are allografts the biologic valve of choice for aortic valve replacement in non-elderly patients? Comparison of explant for structural valve deterioration of allograft and pericardial prostheses. J Thorac Cardiovasc Surg 2005 (in press)
3. Schoen FJ, Levy RJ. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, 28 April-2 May 1999. Tissue heart valves: Current challenges and future research perspectives. J Biomed Mater Res 1999;47:439-465
4. Butany J, Leask R. The failure modes of biological prosthetic heart valves. J Long Term Eff Med Implants 2001;11:115-135
5. Frater RW, Furlong P, Cosgrove DM, et al. Longterm durability and patient functional status of the Carpentier-Edwards Perimount pericardial bioprosthesis in the aortic position. J Heart Valve Dis 1998;7:48-53
6. Edmunds LH, Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112:708-711
7. Schoen FJ, Harasaki H, Kim KM, Anderson HC, Levy RJ. Biomaterial- associated calcification: Pathology, mechanisms, and strategies for prevention. J Biomed Mater Res 1988;22:11-36
8. Allard MF, Thompson CR, Baldell RJ, et al. Commissural region dehiscense from the stent post of Carpentier-Edwards bioprosthetic cardiac valve. Cardiovasc Pathol 1995;4:155-162
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
10. Blackstone EH, Naftel DC, Turner ME, Jr. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986;81:615-624
11. Walley VM, Keon WJ. Patterns of failure in Ionescu- Shiley bovine pericardial bioprosthetic valves. J Thorac Cardiovasc Surg 1987;93:925-933
12. Schoen FJ, Fernandez J, Gonzalez-Lavin L, Cernaianu A. Causes of failure and pathologic findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bioprostheses: Emphasis on progressive structural deterioration. Circulation 1987;76:618-627
13. Thiene G, Bortolotti U, Valente M, et al. Mode of failure of the Hancock pericardial valve xenograft. Am J Cardiol 1989;63:129-133
14. Dagenais F, Cartier P, Voisine P, et al. Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? J Thorac Cardiovasc Surg 2005;129:1041-1049 (discussion)
15. Nollert G, Miksch J, Kreuzer E, Reichart B. Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg 2003;126:965-968
16. Jamieson E. Update on new tissue valves. In: Franco KL (ed.), Advanced therapy in cardiac surgery. BC Decker, Hamilton, Ontario, 2003:177-195
17. Shen M, Kara-Mostefa A, Chen L, et al. Effect of ethanol and ether in the prevention of calcification of bioprostheses. Ann Thorac Surg 2001;71:S413-S416
18. Cunanan CM, Cabiling CM, Dinh TT, et al. Tissue characterization and calcification potential of commercial bioprosthetic heart valves. Ann Thorac Surg 2001;71:S417-S421
19. Duncan AC, Boughner D, Vesely I. Dynamic glutaraldehyde fixation of a porcine aortic valve xenograft. I. Effect of fixation conditions on the final tissue viscoelastic properties. Biomaterials 1996;17:1849-1856
20. Vyavahare NR, Joshi RR, Lee CH, et al. Current progress in anticalcification for bioprosthetic and polymeric heart valves. Cardiovasc Pathol 1997;6:219-229
21. Banbury MK, Cosgrove DM, III, White JA, Blackstone EH, Frater RW, Okies JE. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2001;72:753-757